MICHELLE SARIEV: Open Payments
NPI 1902168610 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,516 in 100 payments from 13 companies in 2025. Trend: 2023 $1,190 · 2024 $1,372 · 2025 $13,516
Speaker / faculty: $10,010Food & beverage: $2,418Travel & lodging: $1,088
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 34 | $12,170 |
| ViiV Healthcare Company | 33 | $665 |
| Merck Sharp & Dohme LLC | 7 | $158 |
| EMD Serono, Inc. | 4 | $115 |
| Novo Nordisk Inc | 4 | $68 |
| Verity Pharmaceuticals Inc. | 4 | $68 |
| Exact Sciences Corporation | 4 | $65 |
| Lilly USA, LLC | 3 | $57 |
| Theratechnologies Inc. | 3 | $54 |
| PFIZER INC. | 1 | $30 |
Products named: Biktarvy, DOVATO, APRETUDE, CABENUVA, PIFELTRO, Tlando, EGRIFTA, The Cologuard Plus Collection Kit.
Industry payments across GA — which companies pay providers there.
